Maravai LifeSciences

$28.45 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Maravai LifeSciences

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.

Stock Analysis

last close $28.45
1-mo return -16.6%
3-mo return -23.7%
avg daily vol. 1.14M
52-week high 63.55
52-week low 23.16
market cap. $3.5B
forward pe 17.5
annual div. -
roe 91.1%
ltg forecast -1.4%
dividend yield -
annual rev. $895M
inst own. -

Subscribe now for daily local and international financial news